Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
DTaP (diphtheria, tetanus, and acellular pertussis) vaccine, which is given to children. DT (diphtheria and tetanus) vaccine, which is given to children. Tdap (combined tetanus, diphtheria and acellular pertussis) vaccine, which is given to adolescents and adults.
Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market is projected to reach US$ 6874.5 million in 2029, increasing from US$ 5315 million in 2022, with the CAGR of 3.7% during the period of 2024 to 2029. Demand from Child and Adult are the major drivers for the industry.
Increasing awareness about the importance of vaccination, growing incidence of diphtheria, tetanus, and pertussis infections, and government immunization programs are key drivers of market expansion. Advancements in vaccine technology, such as the development of acellular pertussis vaccines, have improved safety and efficacy, further boosting market growth. Additionally, the introduction of combination vaccines that provide protection against multiple diseases has simplified immunization schedules and increased convenience for healthcare providers and patients. However, challenges such as vaccine hesitancy, high manufacturing costs, and limited accessibility in certain regions may hinder market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Sanofi
GSK
KM Biologics
Serum Institute of India
Walvax Biotechnology
Sinopharm
Segment by Type
DTaP
Tdap
Segment by Application
Child
Adult
Segment by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine introduction, etc. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Table of Content
1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Overview
1.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Overview
1.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Segment by Type
1.2.1 DTaP
1.2.2 Tdap
1.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Type
1.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Breakdown by Type (2018-2024)
2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Competition by Company
2.1 Global Top Players by Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (2018-2024)
2.2 Global Top Players by Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue (2018-2024)
2.3 Global Top Players by Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Competitive Situation and Trends
2.5.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market
2.8 Key Manufacturers Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Status and Outlook by Region
3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historic Market Size by Region
3.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Market Size by Region
3.3.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine by Application
4.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Segment by Application
4.1.1 Child
4.1.2 Adult
4.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size by Application
4.2.1 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Breakdown by Application (2018-2024)
5 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine by Country
5.1 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historic Market Size by Country
5.1.1 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Country (2018-2024)
5.2 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Market Size by Country
5.2.1 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Country (2024-2029)
6 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine by Country
6.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historic Market Size by Country
6.1.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Market Size by Country
6.2.1 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine by Region
7.1 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Region (2024-2029)
8 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine by Country
8.1 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historic Market Size by Country
8.1.1 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Market Size by Country
8.2.1 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine by Country
9.1 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Products Offered
10.1.5 Sanofi Recent Development
10.2 GSK
10.2.1 GSK Company Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 KM Biologics
10.3.1 KM Biologics Company Information
10.3.2 KM Biologics Introduction and Business Overview
10.3.3 KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Products Offered
10.3.5 KM Biologics Recent Development
10.4 Serum Institute of India
10.4.1 Serum Institute of India Company Information
10.4.2 Serum Institute of India Introduction and Business Overview
10.4.3 Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Products Offered
10.4.5 Serum Institute of India Recent Development
10.5 Walvax Biotechnology
10.5.1 Walvax Biotechnology Company Information
10.5.2 Walvax Biotechnology Introduction and Business Overview
10.5.3 Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Products Offered
10.5.5 Walvax Biotechnology Recent Development
10.6 Sinopharm
10.6.1 Sinopharm Company Information
10.6.2 Sinopharm Introduction and Business Overview
10.6.3 Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Products Offered
10.6.5 Sinopharm Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industrial Chain Analysis
11.4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Dynamics
11.4.1 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industry Trends
11.4.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Drivers
11.4.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Challenges
11.4.4 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Distributors
12.3 Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Figure
List of Tables
Table 1. Major Company of DTaP
Table 2. Major Company of Tdap
Table 3. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (K Units)
Table 5. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (US& Million)
Table 7. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Share in Value by Type (2018-2024)
Table 8. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2024-2029) & (K Units)
Table 10. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Type (2024-2029)
Table 13. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Type (2024-2029) & (USD/Unit)
Table 14. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (K Units)
Table 15. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units) by Type (2018-2024)
Table 17. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units) by Type (2018-2024)
Table 21. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Company (2018-2024) & (K Units)
Table 25. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Share by Company (2018-2024)
Table 26. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue Share by Company (2018-2024)
Table 28. Global Market Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine as of 2022)
Table 32. Date of Key Manufacturers Enter into Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market
Table 33. Key Manufacturers Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Region (2018-2024)
Table 40. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2024-2029) & (K Units)
Table 42. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Region (2024-2029)
Table 45. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 46. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (K Units)
Table 48. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Application (2018-2024)
Table 51. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Application (2024-2029)
Table 56. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Price by Application (2024-2029) & (USD/Unit)
Table 57. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) (K Units)
Table 58. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) (K Units)
Table 60. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) (K Units)
Table 64. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (K Units)
Table 68. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Country (2018-2024)
Table 71. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (K Units)
Table 72. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (K Units)
Table 76. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (K Units)
Table 80. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Country (2024-2029)
Table 107. Sanofi Company Information
Table 108. Sanofi Introduction and Business Overview
Table 109. Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product
Table 111. Sanofi Recent Development
Table 112. GSK Company Information
Table 113. GSK Introduction and Business Overview
Table 114. GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. GSK Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product
Table 116. GSK Recent Development
Table 117. KM Biologics Company Information
Table 118. KM Biologics Introduction and Business Overview
Table 119. KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. KM Biologics Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product
Table 121. KM Biologics Recent Development
Table 122. Serum Institute of India Company Information
Table 123. Serum Institute of India Introduction and Business Overview
Table 124. Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Serum Institute of India Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product
Table 126. Serum Institute of India Recent Development
Table 127. Walvax Biotechnology Company Information
Table 128. Walvax Biotechnology Introduction and Business Overview
Table 129. Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Walvax Biotechnology Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product
Table 131. Walvax Biotechnology Recent Development
Table 132. Sinopharm Company Information
Table 133. Sinopharm Introduction and Business Overview
Table 134. Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Sinopharm Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product
Table 136. Sinopharm Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Trends
Table 140. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Drivers
Table 141. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Challenges
Table 142. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Restraints
Table 143. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Distributors List
Table 144. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Downstream Customers
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Product Picture
Figure 2. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of DTaP
Figure 6. Global DTaP Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Tdap
Figure 8. Global Tdap Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Type in 2022 & 2029
Figure 11. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Type in 2022
Figure 12. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Type in 2022
Figure 13. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Revenue in 2022
Figure 23. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Child
Figure 25. Global Child Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Adult
Figure 27. Global Adult Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share by Application in 2022 & 2029
Figure 30. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Application in 2022
Figure 31. North America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Application in 2022
Figure 32. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Application in 2022
Figure 33. Europe Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Manufacturing Cost Structure
Figure 41. Diphtheria, Tetanus and Acellular Pertussis Combined Vaccine Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices